Assenagon Asset Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-522,578	Closed	-$580K	–	1541
2022 Q4	$580K	Sell	522,578 -277,713	-35%	-$395K	﹤0.01%	1152
2022 Q3	$1.87M	Sell	800,291 -571,100	-42%	-$2.02M	0.01%	734
2022 Q2	$4.16M	Sell	1,371,391 -92,941	-6%	-$452K	0.02%	603
2022 Q1	$9.94M	Buy	1,464,332 +1,251,313	+587%	+$8.92M	0.03%	372
2021 Q4	$1.78M	Sell	213,019 -24	-0%	-$198	0.01%	854
2021 Q3	$1.58M	Sell	213,043 -469,827	-69%	-$2.91M	0.01%	770
2021 Q2	$4.64M	Buy	+682,870	New	+$5.67M	0.02%	498
2019 Q3	–	Sell	-207,200	Closed	-$1.03M	–	1130
2019 Q2	$1.03M	Sell	207,200 -70,900	-25%	-$376K	0.01%	711
2019 Q1	$1.72M	Buy	278,100 +230,109	+479%	+$1.11M	0.02%	564
2018 Q4	$162K	Buy	+47,991	New	+$224K	﹤0.01%	967